Search hospitals > Missouri > Columbia
University of Missouri - Ellis Fischel
Claim this profileColumbia, Missouri 65203
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Ovarian Cancer
417 reported clinical trials
9 medical researchers
Summary
University of Missouri - Ellis Fischel is a medical facility located in Columbia, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Leukemia, Lymphoma, Ovarian Cancer and other specialties. University of Missouri - Ellis Fischel is involved with conducting 417 clinical trials across 333 conditions. There are 9 research doctors associated with this hospital, such as Puja Nistala, Kushal Naha, Christos Papageorgiou, and Gregory Biedermann, MD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Puja NistalaUniversity of Missouri - Ellis Fischel4 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
26 reported clinical trials
86 drugs studied
Kushal NahaUniversity of Missouri - Ellis Fischel4 years of reported clinical research
Studies Bladder Cancer
Studies Prostate Cancer
14 reported clinical trials
43 drugs studied
Christos PapageorgiouMU Health - University Hospital/Ellis Fischel Cancer Center2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
10 reported clinical trials
26 drugs studied
Gregory Biedermann, MDUniversity of Missouri - Ellis Fischel5 years of reported clinical research
Studies Brain Tumor
Studies Breast Cancer
10 reported clinical trials
33 drugs studied
Clinical Trials running at University of Missouri - Ellis Fischel
Lung Cancer
Bladder Cancer
Prostate Cancer
Skin Cancer
Breast Cancer
Ovarian Cancer
Breast cancer
Pancreatic Cancer
Uterine Cancer
Colorectal Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Missouri - Ellis Fischel?
University of Missouri - Ellis Fischel is a medical facility located in Columbia, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Leukemia, Lymphoma, Ovarian Cancer and other specialties. University of Missouri - Ellis Fischel is involved with conducting 417 clinical trials across 333 conditions. There are 9 research doctors associated with this hospital, such as Puja Nistala, Kushal Naha, Christos Papageorgiou, and Gregory Biedermann, MD.
Where is University of Missouri - Ellis Fischel located?
Ellis Fischel Cancer Center is situated on the first two floors of the patient care tower at University Hospital, located at 1 Hospital Drive, Columbia, Missouri. Patients can enter through the Radiation Oncology entrance on the east side of University Hospital, where handicapped-accessible parking is provided. Additionally, Ellis Fischel offers low-cost housing options in partnership with a local hotel for patients living more than 100 miles away and facing hardship with travel.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at the University of Missouri - Ellis Fischel Cancer Center, contact the Financial Counseling Center at 573-884-9900 or toll-free 1-866-608-8025, Monday through Friday, 8 a.m. to 4:30 p.m. Email patientf@health.missouri.edu or fax documents to 573-884-4979. Financial counselors assist with financial assistance applications, Medicaid, and provide price estimates for procedures.
What insurance does University of Missouri - Ellis Fischel accept?
The University of Missouri - Ellis Fischel Cancer Center accepts a wide range of insurance plans. These include, but are not limited to, Aetna, Anthem Blue Cross and Blue Shield, Cigna, Coventry Health Care, First Health PPO, HealthLink, Healthy Blue, Humana Medicare, Medica, MultiPlan PPO, Optum Behavioral Health, TRICARE, UnitedHealthcare, and Wellcare. Patients are advised to confirm their specific insurance plan with the hospital or financial counseling representatives to ensure coverage.
What awards or recognition has University of Missouri - Ellis Fischel received?
The University of Missouri's Ellis Fischel Cancer Center is recognized for its commitment to advancing cancer care through research and innovation, notably as part of the National Cancer Institute's Community Oncology Research Program (NCI-CORP). Located on a campus with comprehensive facilities and schools, including a medical school and veterinary medicine college, it benefits from access to the nation's most powerful research reactor and the NextGen Precision Health initiative. Additionally, the center offers a Summer Undergraduate Research Fellowship (SURF) program, allowing undergraduate students to engage in cancer research projects under the guidance of faculty mentors.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.